Latest Breaking News On - Be biopharma inc - Page 2 : comparemela.com

Be Biopharma Expands Leadership Team as Company Transitions to Clinical Stage Organization

Be Biopharma Expands Leadership Team as Company Transitions to Clinical Stage Organization
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAngus smithLos angelesJoanne smith farrellDavid rawlingsRichard jamesAtlas ventureBristol myers squibbGroup viceHead of clinical researchAdvisory committee on blood safetyKeck school of medicineOccidental collegeSeattle children research instituteLongwood fund

Be Biopharma to Present at the 42nd Annual J P Morgan Healthcare Conference

Be Biopharma to Present at the 42nd Annual J P Morgan Healthcare Conference
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesJoanne smith farrellDavid rawlingsRichard jamesBe biopharma incSeattle children research instituteLongwood fundAtlas ventureBristol myers squibbEngineeredb cell medicinesChief executive officer joanne smith farrellHealthcare conferenceNew classSeattle childrenAlta partners

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B

SAN DIEGO (BUSINESS WIRE) Dec 10, 2023

United statesSan diegoRichard jamesJoanne smith farrellRichard morganDavid rawlingsRicharda morganAtlas ventureUs department of healthOral presentation at american society of hematologyAmerican society of hematologyBlood products advisory committeeHemophiliab national bleeding disorders foundationCommittee on blood safetyWorld federation of hemophiliaUs centers for disease

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoDavid rawlingsRicharda morganRichard jamesRichard morganJoanne smith farrellLongwood fundHuman servicesAmerican society of hematologyCommittee on blood safetyOral presentation at american society of hematologyHemophiliab national bleeding disorders foundationWorld federation of hemophiliaAtlas ventureBlood products advisory committee

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-1

BE-101 is Company’s Lead Program in Hemophilia B; IND Filing Anticipated in Mid-2024Be Bio Appoints Glenn Pierce, M.D., Ph.D., Hemophilia Physician-Researcher and Advocate, to its Scientific Advisory BoardPreclinical Study Findings Shared in Oral Presentation During 65th Annual Meeting of the American Society of Hem.

San diegoUnited statesRicharda morganDavid rawlingsRichard jamesJoanne smith farrellBristol myers squibbUs department of healthHemophiliab national bleeding disorders foundationDrug administrationLongwood fundHuman servicesSeattle children research instituteAmerican society of hematologyUs centers for diseaseBlood products advisory committee